Serena Di Cosimo

Has grant

Open University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Immune response offers major clue for treatment de-escalation in HER2 positive breast cancer patients

Open Date: 2018-01-01

Close Date: 2022-12-01

Grant: Close

From clinical trials to clinical practice: challenging ct-miR trial data to real world HER2 positive breast cancer management

Open Date: 2018-01-01

Close Date:

Grant: Close

Extracellular matrix regulation of myeloid cell contexture shapes the fate of oncogenic events

Open Date: 2017-01-01

Close Date:

Grant: Close

Targeting the inhibitor of apoptosis proteins (IAPs) as a novel strategy to hinder microenvironment-dependent cancer aggressiveness

Open Date: 2017-01-01

Close Date:

Grant: Close

Gene expression profiling of HER2 and Hormone Receptor positive breast cancer fit to individualized HER2 targeted treatment

Open Date: 2016-01-01

Close Date: 2018-12-01

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (14)

Tiziana Triulzi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

paolo verderio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Giulia Cosentino

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Sherene Loi

University of Melbourne

AUSTRALIA

View details

Sara Pizzamiglio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Elda Tagliabue

Head of Molecular Targeting Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Paolo Zucali

Associate Professor of Medical Oncology

Humanitas University

ITALY

View details

Mattia Rediti

Université libre de Bruxelles (ULB)

BELGIUM

View details

Trama Annalisa

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Vera Cappelletti

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Roberto Lillini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Juan Rafael de la Haba Rodríguez

Profesor Titular

Universidad de Córdoba

SPAIN

View details

Alice Bernasconi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

DANIELE GENERALI

University of Trieste

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Serena Di Cosimo

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (15)

Acquired HER2 expression promotes secondary metastasis in breast cancer

Towards precision therapy in HER2-positive early-stage breast cancer

Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells

From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer

Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial

Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients

Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma

Advancing Circulating Tumor DNA for Recurrent Breast Cancer

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab

COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer

Nobody dares stopping clinical research, not even COVID-19

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study

Collaborators (14)

Tiziana Triulzi

paolo verderio

Giulia Cosentino

Sherene Loi

Sara Pizzamiglio

Elda Tagliabue

Paolo Zucali

Mattia Rediti

Trama Annalisa

Vera Cappelletti

Roberto Lillini

Juan Rafael de la Haba Rodríguez

Alice Bernasconi

DANIELE GENERALI

Make your next move.